Newsletter
Odd Bta Fta Status
News filed under ODD/BTA/FTA Status, newest first.
Showing 1–5 of 10 stories
Latest story
Consano Bio’s C-1101 Receives FDA Fast Track Designation for Chronic Sciatica
FDA Designation Supports Development of Potential Treatment for Chronic Lumbosacral Radiculopathy...
Read story
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
A Major Step Forward for SMA Treatment Biogen has announced that the U.S. Food and Drug Administr...
Read story
Thryv Therapeutics Advances THRV-1268 in Long QT Syndrome
Fast Track status + Phase 2/3 dosing marks a critical inflection point. A small biotech just made a...
Read story
Eris Lifesciences Disrupts the GLP-1 Market with ₹220 Semaglutide Shot
The semaglutide price war in India just hit a new low. Eris Lifesciences Limited has launched its ge...
Read story
US FDA grants Breakthrough Therapy designation to Sanofi’s venglustat for type 3 Gaucher disease
Sanofi announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy des...
Read storyPage 1 of 2
